tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CANF Stock Latest News

Can-Fite Reports Breakthrough in Liver Cancer Treatment
Company AnnouncementsCan-Fite Reports Breakthrough in Liver Cancer Treatment
3h ago
6K
CANF
Can-Fite’s Namodenoson Shows Promise for Liver Cancer
PremiumCompany Announcements
Can-Fite’s Namodenoson Shows Promise for Liver Cancer
10d ago
6K
CANF
Can-Fite: Article by KOL presents Namodenoson to treat liver cancer, MASH
PremiumThe Fly
Can-Fite: Article by KOL presents Namodenoson to treat liver cancer, MASH
10d ago
CANF
Can-Fite Advances MASH Treatment into Phase IIb
PremiumCompany Announcements
Can-Fite Advances MASH Treatment into Phase IIb
22d ago
6K
CANF
Can-Fite BioPharma submits IND to FDA for Phase IIb trial of namodenoson
PremiumThe Fly
Can-Fite BioPharma submits IND to FDA for Phase IIb trial of namodenoson
22d ago
CANF
US Investors Beware: Tax Complications for Can-Fite BioPharma Shareholders
PremiumCompany AnnouncementsUS Investors Beware: Tax Complications for Can-Fite BioPharma Shareholders
27d ago
CANF
Can-Fite BioPharma Reports Reduced Losses in 2023
PremiumCompany Announcements
Can-Fite BioPharma Reports Reduced Losses in 2023
28d ago
6K
CANF
CANF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
CANF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
CANF
Can-Fite expands IP for NASH, gets patent allowance in Canada
PremiumThe Fly
Can-Fite expands IP for NASH, gets patent allowance in Canada
2M ago
CANF
Can-Fite BioPharma expands out licensing transaction with Ewopharma
PremiumThe Fly
Can-Fite BioPharma expands out licensing transaction with Ewopharma
3M ago
CANF
Can-Fite says journal publishes data from the COMFORT-1 psoriasis study
PremiumThe Fly
Can-Fite says journal publishes data from the COMFORT-1 psoriasis study
3M ago
CANF
Can-Fite BioPharma gets positive response from FDA to psoriasis pediatric plan
PremiumThe Fly
Can-Fite BioPharma gets positive response from FDA to psoriasis pediatric plan
4M ago
CANF
Can-Fite BioPharma: Enrollment ongoing in study of Namodenoson in liver cancer
PremiumThe FlyCan-Fite BioPharma: Enrollment ongoing in study of Namodenoson in liver cancer
5M ago
CANF
Can-Fite BioPharma reports 9month net loss $5.98M vs. net loss of $7.15M
PremiumThe Fly
Can-Fite BioPharma reports 9month net loss $5.98M vs. net loss of $7.15M
5M ago
CANF
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
AQST
BCLI
Is CANF a Buy, Before Earnings?
PremiumPre-Earnings
Is CANF a Buy, Before Earnings?
5M ago
CANF
Can-Fite BioPharma trading resumes
PremiumThe Fly
Can-Fite BioPharma trading resumes
5M ago
CANF
Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
PremiumPress Releases
Can-Fite Announces Exercise of Warrants for Approximately $3.0 Million in Gross Proceeds
5M ago
CANF
Can-Fite BioPharma trading halted, news pending
PremiumThe Fly
Can-Fite BioPharma trading halted, news pending
5M ago
CANF
Can-Fite: Complete response in patient with HCC treated with namodenoson
PremiumThe FlyCan-Fite: Complete response in patient with HCC treated with namodenoson
5M ago
CANF
Can-Fite BioPharma price target lowered to $18 from $34 at H.C. Wainwright
PremiumThe Fly
Can-Fite BioPharma price target lowered to $18 from $34 at H.C. Wainwright
6M ago
CANF
Can-Fite shares “Lowe Syndrome Novel Treatment” with Japan orphan drug company
PremiumThe Fly
Can-Fite shares “Lowe Syndrome Novel Treatment” with Japan orphan drug company
7M ago
CANF

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >